Aileron Therapeutics
Clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases. Learn more
Launch date
Employees
Market cap
€54.0m
Enterprise valuation
€38m (Public information from Sep 2024)
Share price
$2.91 ALRN
Cambridge Massachusetts (HQ)
Authorizing premium user...